CompletedNot Applicable

Safety and Efficacy Evaluation of CO2 Removal in Combination With Continuous Veno-Venous Hemodialysis/Hemodiafiltration Therapy

Germany28 participantsStarted 2022-03-25

Plain-language summary

Objective of the study is to assess the safety and efficacy of CO2 removal by the multiECCO2R (CO2 Removal System) on the multiFiltrate/multiFiltrate Pro in veno-venous extracorporeal circulation during continuous renal replacement therapy (CRRT) in patients presenting with hypercapnia due to acute lung failure and acute kidney injury.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. if patient is able to give consent: by the study patient
✓. if patient is unable to give consent: by the legal representative or
✓. if an emergency situation is determined: by an independent consultant physician

What they're measuring

Clinical efficiency variables: Change of PaCO2

Timeframe: 30 minutes after start of treatment

Trial details

NCT IDNCT04871893

SponsorFresenius Medical Care Deutschland GmbH

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2024-12-06

View on ClinicalTrials.gov More Acute Lung Injury trials